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Abstract
Aim: To provide a clinical and economic rationale for the comprehensive examination of patients
with chronic obstructive pulmonary disease (COPD), by using functional and ultrasound methods
for  the early  detection of  cardiac  comorbidity.  Subjects  and methods:  Three hundred and
sixteen patients (33 with COPD, 44 with COPD + hypertension, 73 with COPD + coronary heart
disease (CHD), 36 with hypertension, 50 with CHD, 19 with asthma, and 28 with asthma +
hypertension)  and  33  apparently  healthy  individuals  were  examined  using  611  indicators
obtained directly or by calculation during echocardiography, carotid artery duplex scanning, and
24-hour electrocardiographic (ECG) and blood pressure (BP) monitoring. Results: Cardiovascular
diseases develop in patients with COPD in its early stages. In cardiac comorbidity, the length of
hospital stay increases by 1-1.5 days in patients with COPD; the number of people admitted to
hospital more than once every 3 years rises from 14 to 28%; the cost of a pharmacotherapy
cycle  is  1.35-  and 2.95-fold  higher  when COPD is  concurrent  with  hypertension and CHD,
respectively.  Conclusion: In addition to ECG and spirometry, the management standard for
patients with COPD should include echocardiography, 24-hour ECG and BP monitoring, and,
according to their results, carotid artery duplex scanning.
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